New York, NY (PRWEB) April 18, 2013
On April 18, 2013, Voices Against Brain Cancer comments on a Medical Daily article where stem cells from fat tissue were used during brain surgery to chase cancer cells after the brain tumors were removed.
According to the Medical Daily article by Ansa Varughese, the study showed that stem cells from fat tissue can be used to track difficult regions in the brain prone to remission. Scientists cannot yet determine why or how these stem cells target the prone areas, but the cells seem naturally drawn to the damaged areas. Researchers are using the stem cells as transporters to help deliver drugs for treatment in the cancer spreading regions of the brain.
Alfredo Quinones-Hinojosa, the lead researcher and professor of neurosurgery, oncology, and neuroscience at Johns Hopkins, was quoted in the article as saying, “The biggest challenge in brain cancer is the migration of cancer cells. Even when we remove the tumor, some of the cells have already slipped away and are causing damage somewhere else. Building off our findings, we may be able to find a way to arm a patient's own healthy cells with the treatment needed to chase down those cancer cells and destroy them. It's truly personalized medicine.”
The Medical Daily article goes on to mention that harvesting the mesenchymal stem cells from the fat tissue is safer than getting the cells from bone marrow. While it will still take years before a clinical trial happens in the U.S., the new stem cell treatment could play a major part in battling brain cancer.
Michael Klipper, Chairman of VABC, offers his comments on the new study. “This is a great step toward battling brain cancer. While it’s still a new study, it seems to be having positive results, and can hopefully become something used in brain cancer treatment in the future. Dealing with brain tumors and the treatment after can be a major, painful ordeal. Hopefully this new study will lead to a new way patients can be treated after they’ve had a tumor removed.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.